GSK report: Ireland needs a national adult vaccination strategy to address an ageing population

GSK paid the former Irish deputy chief medical officer to produce a report pushing for a national adult immunisation strategy, similar to childhood vaccination programmes, to align Ireland’s vaccination policies with the World Health Organisation’s policies.  The report claims this is needed because Ireland’s population is ageing.

Last week, The Irish Times published an article about a report commissioned by the pharmaceutical giant GlaxoSmithKline (“GSK”).  Unsurprisingly, the report says that an ageing population in Ireland means the need for vaccination is growing and called for a “stand-alone national adult immunisation strategy.”

“The benefit of vaccination is growing more and more over time,” Ronan Glynn, the author of GSK’s report said. “Flu is a really good example. Every year up to 500 people in Ireland die from flu and thousands are admitted to hospital every winter. While vaccination won’t remove that risk entirely, it lessens the severity and impact both on individuals and the health system when it’s under the most pressure.”

GSK’s report does not focus on specific vaccines. Instead, it looks at the system of adult vaccination, making reference to a number of injections including shingles, flu, pneumococcal and RSV.  GSK’s vaccine portfolio consists of more than 20 marketed vaccines, one of the industry’s broadest.

Among the paper’s recommendations, the authors call for increased vaccination points nationwide such as in pharmacies, workplaces, hospitals and mobile clinics; including education on immunisation in the school curriculum; and implementing a “comprehensive” immunisation IT system, according to The Irish Times.

Ronan Glynn is the former deputy chief medical officer of Ireland and is now the health lead at accounting and consulting firm Ernst & Young.  As Patrick E Walsh pointed out, in 2021 Glynn was a major pusher and persuader for the covid-19 vaccine programme.

“One would think that considering the amount of death and illness left in the wake of this policy that Glynn would shut up, but not our Ronan,” Walsh said.  He left a government role and walked straight into a position as health lead at Ernst & Young Consultants, “That’s how things roll in ‘Official Ireland’.  You walk with a strut from a taxpayer-funded job designed to protect Irish citizens into a role as a consultant for the industry that recent history shows they need the most protection from.”

But that’s not all.  Glynn’s wife, Carla O’Brien has been working at RTÉ, Ireland’s national radio and television service, as a “journalist” since 2011 until September 2023 when she became the presenter of RTÉ’s Crimecall.

GSK’s Vision for Adult Immunisation in Ireland

Glynn/GSK’s vision for adult immunisation in Ireland is to create a comprehensive and integrated strategic approach, aligned with the World Health Organisation’s (“WHO”) Immunisation Agenda 2030, which aims to ensure that everyone benefits from vaccines at every age.

“While vaccination programmes have traditionally focused on paediatric populations, there is a growing recognition of the need to bridge the vaccine gap for adults. The WHO’s Immunisation Agenda 2030 envisions a world where everyone benefits from vaccines at every age. A ‘life course’ approach to immunisation is becoming more common, emphasising immunisation at all life stages and ensuring the successes of childhood vaccination extend to adults.”—Executive summary, 2024-2025: Vision & Strategic Approach to Adult Immunisation in Ireland, GSK, January 2025

Related: Immunisation Agenda 2030: Bill Gates’ latest plan to vaccinate every man, woman and child on Earth

The importance of adult immunisation, the executive summary of GSK/Glynn’s report says, is paramount in Ireland, particularly given the country’s rapidly ageing population, with the over-65 population predicted to double by 2051, and the increasing incidence of chronic diseases, with 74% of over 58-year-olds living with comorbidities.

The report doesn’t mention that previous vaccination programmes, such as the mass covid injection programmes, are responsible for some of those comorbidities.

One of the stated motivations for an adult immunisation strategy is to save money.  The report claims that the benefits of adult immunisation include improvements in population health (a dubious claim), reductions in healthcare costs and resource use, and increases in societal productivity and economic gains, with comprehensive adult immunisation programmes potentially saving up to €23 for every €1 spent in Ireland.

As with all the pandemic-vaccine industry plans, they get tripped up by people who speak out and will not comply.  So, tackling information they label as “misinformation” is always high on the agenda.

To achieve GSK/Glynn’s plan for adult immunisation in Ireland, the report recommends four strategic priorities including building trustworthy vaccination programmes, promoting vaccine literacy and investing in a whole-of-government approach to immunisation, with the first priority being to resource the Health Service Executive’s (“HSE’s”) National Immunisation Office (“NIO”) to standardise vaccine messaging and promote vaccine literacy.

The report recommends the recommencement of the National Vaccine Alliance to promote evidence-based communication on adult immunisation, and funding should be allocated to research public attitudes towards immunisation and combat misinformation.

The report also suggests that “immunisation champions” should be designated in each HSE Health Region to ensure cohesive communication and implementation of immunisation programmes and a service delivery model prioritising equitable access should be developed, offering multiple entry points to vaccination.

To sum up what the report is suggesting, they want to control the narrative and make it possible to get injections into as many arms as possible.

The report goes on to suggest that a data-driven approach to immunisation should be leveraged, utilising accurate vaccination and population data, and a comprehensive immunisation information system should be implemented.  Key performance indicators (“KPIs”) should be developed and monitored to track strategy implementation and programme performance.

The Health Information Bill should be progressed, the report says, and the integration of immunisation data within the planned Shared Care Record and/or Electronic Health Records (“EHRs”) should be prioritised, as should the inclusion of an immunisation module on the HSE’s Patient App.

Does this sound like a similar scheme to the track and trace measures that governments attempted to implement for covid?

Confirming this is part of a European-wide and global agenda, the report says that the NIAC should be recognised as a National Immunisation Technical Advisory Group (“NITAG”) to align with European and WHO standards, and a “formal horizon scanning process” should be established to publish an updated immunisation roadmap on accessible platforms.

The implementation of the recommended approach to adult immunisation in Ireland can lead to the development of a comprehensive national strategy, ultimately enhancing public health and protecting vulnerable populations, as outlined in the World Health Organisation’s ‘Immunisation Agenda 2030: A global strategy to leave no one behind’, the report says.

Adding that a life-course approach to vaccination, as suggested by The Health Policy Partnership, can help adapt European policies to vaccinate different age groups, including older adults.

The report says that the growing threat of antibiotic resistance, as noted by the European Centre for Disease Prevention and Control, further emphasises the need for effective vaccination programmes, and with numerous vaccines in development, as reported by Pharmaceutical Research and Manufacturers of America and Vaccines Europe, Ireland is well-positioned to take advantage of future vaccine innovations and improve its adult immunisation strategy.

Coincidentally, in October 2024, WHO published a report that provided “key stakeholders with recommendations for enhancing the impact of vaccines on AMR [antimicrobial resistance].”  In its announcement of the report, WHO reminded key stakeholders that “at the 79th United Nations General Assembly High-Level Meeting on AMR on 26 September, world leaders approved a political declaration committing to a clear set of targets and actions, including reducing the estimated 4.95 million human deaths associated with bacterial AMR annually by 10% by 2030.”  WHO’s scheme hopes that vaccines against 23 pathogens could reduce the use of antibiotics by 2.5 billion doses annually.  How many vaccine doses will that “require”?

By adopting a strategic approach to adult immunisation, the GSK/Glynn’s report claims, Ireland can stay ahead of emerging health threats, protect its population and contribute to the global effort to improve public health, as envisioned by the World Health Organisation and supported by research from various organisations, including the Office of Health Economics and the European Centre for Disease Prevention and Control.

Worryingly, the report notes that there are approximately 300 vaccines in development worldwide, and 80% of these efforts are aimed towards adults.  It seems covid measures, such as track and tracing and its so-called “vaccines,” were just the beginning for pharmaceutical companies to bolster and grow their profits. Not to mention that they appear to be targeting the elderly as they did during the covid “pandemic.”

The above is partly paraphrased from a 3-page summary of GSK/Glynn’s report which you can read HERE.  You can read the full GSK report HERE.

Featured image: Dr. Ronan Glynn